SKVY yields 2000000.00% · PFE yields 6.13%● Live data
📍 SKVY pulled ahead of the other in Year 1
Combined, SKVY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKVY + PFE for your $10,000?
Sentry Technology Corp. designs, manufactures, markets, and services closed circuit television (CCTV), library patron self service, and radio frequency identification (RFID) solutions, as well as EAS security systems. It offers SentryVision SmartTrack, a traveling video system that transmit images from a PTZ camera mounted on a carriage that travels along a rail mounted to the ceiling of any facility; VideoRailway, a traveling camera technology; security and information services through inventory management, self-service, and book detection systems to school, public, and academic libraries; and OperationalVideo, a browser based video application to assist retailers with real time management of security, merchandising audits, and employee procedure compliance. The company also offers EAS security systems, including electromagnetic and RF systems for reducing theft in bookstores; and designs, installs, and maintains CCTV systems for retailers, transportation and distribution, and commercial and industrial companies. It serves retailers, transportation and distribution hubs, couriers and public transportation facilities, libraries, and data centers through dealers in North America, Europe, Latin America, the Middle East, Asia, and Africa. The company was founded in 1996 and is based in Ronkonkoma, New York.
Full SKVY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.